This weight-loss drug, designed for obese patients, significantly reduces breathing disruptions and offers a new treatment ...

Some traditional fairy tales and classic children's fiction that have soothed many a child to sleep may also provide ...

The new approval means that insurance providers will likely cover the medication for people with sleep apnea and obesity.

T he weight-loss drug Zepbound (tirzepatide) now has another major benefit: on Dec. 20, it became the first drug approved by ...

Sleep breathing problems, like sleep apnea, may lead to changes in the hippocampus and white matter, impacting brain health ...

The Food and Drug Administration expanded the approval of weight loss drug Zepbound to treat obstructive sleep apnea in ...

According to a Canadian study, these stories could also become excellent educational aids for teaching children the ...

A new study published in the journal of Sleep and Breathing showed that a higher risk of moderate-to-severe obstructive sleep ...

A recent study published in the Journal Children found that nocturnal enuresis is significantly prevalent in children with ...

Sleep apnea – a disorder in which breathing stops and starts during the night – may cause damage to small blood vessels in ...

The Food and Drug Administration (FDA) approved a weight-loss drug to help sleep apnea, becoming the first drug to treat the disorder affecting millions of Americans. On Friday, the federal agency ...